243 related articles for article (PubMed ID: 8326131)
1. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
2. Anti-human kappa opioid receptor antibodies: characterization of site-directed neutralizing antibodies specific for a peptide kappa R(33-52) derived from the predicted amino terminal region of the human kappa receptor.
Buchner RR; Vogen SM; Fischer W; Thoman ML; Sanderson SD; Morgan EL
J Immunol; 1997 Feb; 158(4):1670-80. PubMed ID: 9029103
[TBL] [Abstract][Full Text] [Related]
3. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
4. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
[TBL] [Abstract][Full Text] [Related]
5. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
Nikiforovich GV; Marshall GR; Baranski TJ
Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic peptides against human anaphylatoxin C5a.
Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
[TBL] [Abstract][Full Text] [Related]
7. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
Tardif M; Mery L; Brouchon L; Boulay F
J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
[TBL] [Abstract][Full Text] [Related]
8. CD88 antibodies specifically bind to C5aR on dermal CD117+ and CD14+ cells and react with a desmosomal antigen in human skin.
Werfel T; Zwirner J; Oppermann M; Sieber A; Begemann G; Drommer W; Kapp A; Götze O
J Immunol; 1996 Aug; 157(4):1729-35. PubMed ID: 8759762
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis.
Morgan EL; Sanderson S; Scholz W; Noonan DJ; Weigle WO; Hugli TE
J Immunol; 1992 Jun; 148(12):3937-42. PubMed ID: 1602137
[TBL] [Abstract][Full Text] [Related]
10. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
Zahn S; Zwirner J; Spengler HP; Götze O
Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
[TBL] [Abstract][Full Text] [Related]
11. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
12. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
[TBL] [Abstract][Full Text] [Related]
13. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
Elsner J; Oppermann M; Kapp A
Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
[TBL] [Abstract][Full Text] [Related]
14. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
Tardif M; Brouchon L; Rabiet MJ; Boulay F
Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
[TBL] [Abstract][Full Text] [Related]
15. Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.
Wilmer WA; Kaumaya PT; Ember JA; Cosio FG
J Immunol; 1998 Jun; 160(11):5646-52. PubMed ID: 9605171
[TBL] [Abstract][Full Text] [Related]
16. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
17. Discovery of human antibodies against the C5aR target using phage display technology.
Huang L; Sato AK; Sachdeva M; Fleming T; Townsend S; Dransfield DT
J Mol Recognit; 2005; 18(4):327-33. PubMed ID: 15706605
[TBL] [Abstract][Full Text] [Related]
18. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke.
Floreani AA; Heires AJ; Welniak LA; Miller-Lindholm A; Clark-Pierce L; Rennard SI; Morgan EL; Sanderson SD
J Immunol; 1998 May; 160(10):5073-81. PubMed ID: 9590258
[TBL] [Abstract][Full Text] [Related]
20. The role of the ribosomal protein S19 C-terminus in altering the chemotaxis of leucocytes by causing functional differences in the C5a receptor response.
Nishiura H; Zhao R; Yamamoto T
J Biochem; 2011 Sep; 150(3):271-7. PubMed ID: 21613290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
